TRANSMEDICS GROUP INC (TMDX)
US89377M1099 - Common Stock
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
Is TransMedics Stock a Buy Before 2025?
2 Healthcare Stocks to Buy Hand Over Fist and 1 to Avoid
Down Over 60%, Is TransMedics Stock a Buy on the Dip?
Why Transmedics Group Stock Plummeted 21% This Week
3 Cheap Stocks to Buy Now
Three stocks poised for upside, both near-term and long-term.
TMDX INVESTIGATION: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving TransMedics...
Oversold Conditions For TransMedics Group (TMDX)
Notable Tuesday Option Activity: TMDX, UPST, LLY
Why TransMedics Stock Plummeted Today
Monday's after hours session: top gainers and losers
Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top gainers and losers in today's after hours session.
TransMedics Appoints Gerardo Hernandez as Chief Financial Officer and Provides Updated 2024 Financial Outlook
/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
TransMedics to Host Investor & Analyst Day on December 10, 2024
/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
1 Top Growth Stock Down 56% to Buy After Its Recent Pullback
This growth stock has been on my watchlist for a while and might soon be included in my portfolio.
2 Hypergrowth Stocks That Are Screaming Buys in November
TransMedics to Participate in the Piper Sandler 36th Annual Healthcare Conference
/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
Is TransMedics Group Stock a Buy?
This organ transplant specialist is down, but still has plenty of signs of life.
Down 52%, Is TransMedics Stock a Buy on the Dip?
Sales growth is tapering off for this provider of delivery services for transplant organs.
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into TransMedics Group, Inc. (NASDAQ: TMDX)
Why TransMedics Stock Plunged in October
The organ transplant specialist posted disappointing results in its third-quarter report.
1 Top Growth Stock Down 50% to Buy After Its Recent Pullback
TransMedics quickly became the leader in liver, heart, and lung transplants, but its third-quarter earnings left the market worried. Here's why I believe its pullback in share price is an opportunity.
TMDX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving TransMedics...
Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review
The major indexes declined, but haven't fallen apart.
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...